SeaStar Medical Holding Corporation (ICU)
NASDAQ: ICU · Real-Time Price · USD
0.8384
-0.2116 (-20.15%)
At close: Nov 13, 2026, 4:00 PM EST
0.8780
+0.0396 (4.72%)
After-hours: Nov 13, 2026, 7:58 PM EST
SeaStar Medical Holding Market Cap
SeaStar Medical Holding has a market cap or net worth of $4.41 million as of November 13, 2026. It is the 44,325th most valuable company in the world and the 5,860th biggest in the United States. Its market cap has decreased by 75.37% in one year.
Market Cap
4.41M
Enterprise Value
421.69K
1-Year Change
-75.37%
Global Rank
Country Rank
#5,860 United States
Category
ChartMarket Cap Chart
Since July 13, 2022, SeaStar Medical Holding's market cap has decreased from $132.89M to $4.41M, a decrease of -96.68%. That is a compound annual growth rate of -54.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 4.41M | -49.02% |
| Dec 31, 2025 | 8.65M | -0.08% |
| Dec 31, 2024 | 8.66M | -56.05% |
| Dec 29, 2023 | 19.70M | -62.16% |
| Dec 30, 2022 | 52.07M | -60.82% |
| Jul 13, 2022 | 132.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vyome Holdings | 11.02M |
| Lisata Therapeutics | 10.81M |
| Intensity Therapeutics | 10.71M |
| Longeveron | 10.52M |
| Purple Biotech | 10.49M |
| CytoMed Therapeutics | 10.03M |
| Chemomab Therapeutics | 9.78M |
| Lexaria Bioscience | 9.77M |